Targeted Therapy of Acute Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Targeted Therapy of Acute Myeloid Leukemia by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493913930
Publisher: Springer New York Publication: November 20, 2014
Imprint: Springer Language: English
Author:
ISBN: 9781493913930
Publisher: Springer New York
Publication: November 20, 2014
Imprint: Springer
Language: English

This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future.

More books from Springer New York

Cover of the book Active Assessment: Assessing Scientific Inquiry by
Cover of the book Evaluating a Large Group Awareness Training by
Cover of the book Residue Reviews by
Cover of the book Human Development and Criminal Behavior by
Cover of the book Introduction to Hardware Security and Trust by
Cover of the book Biomimetics in Materials Science by
Cover of the book Magnetic Resonance Angiography by
Cover of the book Models of Psychopathology by
Cover of the book Fundamentals of Biomechanics by
Cover of the book Cell Formation in Industrial Engineering by
Cover of the book Lateral Gene Transfer in Evolution by
Cover of the book Integrated Optics by
Cover of the book Nanoscale Photonics and Optoelectronics by
Cover of the book Comprehensive Guide to Education in Anesthesia by
Cover of the book HIV/AIDS Treatment in Resource Poor Countries by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy